Crizotinib treatment also decreased the level of several cancer protein biomarkers, including CA724, CA199 and CA242, plasma concentration of total cell free DNA (cfDNA) and MET relative copy number (Figure 1B and 1C). The gene discussed is MET; the disease is cancer.